No differences between pre-existing diabetes and COVID-associated hyperglycaemia were evident for the IgG, IgM, and IgA responses to the SARS-CoV-2 spike protein (RBD or S1 + S2) or in IgG response to NP, autoimmune antibodies anti GAD, and anti-interferon alpha-4. The gene discussed is CD79A; the disease is Hyperglycemia.